AVIENCE — Avience Biomedicals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Avience Biomedicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.249	2.45	3.57	49.4	29.3
Net Total Accounts Receivable
Net Total Receivables	30.7	30.9	102	191	229
Total Inventory
Total Other Current Assets
Total Current Assets	45.6	68.8	230	372	432
Net Property, Plant And Equipment	15.1	29.9	101	176	288
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	60.9	100	347	565	746
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30.9	57.3	208	236	296
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	33	59.5	284	338	432
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	27.9	40.7	62.1	227	314
Total Liabilities & Shareholders' Equity	60.9	100	347	565	746
Total Common Shares Outstanding